SANTA ANA – A former Angel star was convicted Friday of insider-trading, following a two-month trial in which the ex-ballplayer was accused of illegally using non-public information from a CEO friend to net $1.3 million.

Doug DeCinces, who once played third base for the Orioles and the Angels, was accused of receiving insider information from James Mazzo, a Laguna Beach neighbor who owned Santa Ana-based Advanced Medical Optics.

In turn, federal prosecutors said, DeCinces passed the inside information on to his friend David Parker of Ladera Ranch and other DeCinces family members and acquaintances.

Jurors deliberated for four days before finding DeCinces guilty of 14 felony counts. Parker was convicted of three felonies.

Each count carries a potential maximum sentence of 20 years in federal prison.

DeCinces, now 66, stared toward the jury, shaking his head slightly, as the guilty verdicts were read. Watching from the courtroom audience were a half-dozen DeCinces family members and friends who sat through the entire trial.

Jurors were unable to reach a decision regarding an additional fifteen counts against DeCinces, deadlocking 8 to 4 in favor of guilt.

While jurors were apparently convinced that DeCinces and Parker, 65, both used non-public information for their own financial benefit, they didn’t come to an agreement as to whether Mazzo, 60, actually provided the pair with the insider information.

The jury deadlocked on the counts involving Mazzo, leading U.S. District Court Judge Andrew J. Guilford to declare a mistrial for him. Federal officials haven’t announced if they will re-try Mazzo.

Prosecutors, as well as attorney’s for Mazzo and Parker, declined to comment following the verdict.

DeCinces attorney, Ken Julian, indicated that he plans to file a motion for a new trial, although he declined to outline his arguments for doing so.

“Obviously, this is a disappointment for everybody involved,” Julian said. “This is not the end.”

The judge allowed DeCinces and Parker to remain free pending sentencing after both men promised Guilford that they will return to court. A sentencing date has not been set.

The bulk of the trial focused on trades the defendants made prior to Advanced Medical Optics being bought out by larger Abbott Laboratories. The 2008 merger came as Advanced Medical Optics, which made equipment for LASIK surgery as well as contact lens-related products, struggled to deal with falling revenue and rising debt in the midst of a Wall Street crash.

Prosecutors alleged that DeCinces was tipped by Mazzo to the impending merger between the two companies. Abbott ultimately agreed to purchase Advanced Medical Optics at around four times the stock price at which it was trading.

Stock trades at the time of the Abbott deal made DeCinces about $1.3 million, while Parker and another half-dozen he was accused of tipping off made another $1.3 million.

Attorneys for DeCinces, Mazzo and Parker flatly denied the charges, accusing the government of carrying out a shoddy investigation and relying on speculation and conjecture during the trial.

The defense attorneys told jurors there was no direct evidence Mazzo passed insider information to DeCinces, contending that the former ballplayer was instead buying Advanced Medical Optics stock on the advice of another friend, a veteran trader.

DeCinces spent 15 seasons in the major leagues, making his name with the Baltimore Orioles before arriving in Orange County via trade in 1982. He spent six years with the Angels, making the American League All-Star team in 1983 before getting released in 1987.

In August 2011, the Securities and Exchange Commission charged DeCinces, along with Mazzo and Parker, of insider trading.

DeCinces paid $2.5 million to settle the SEC charges, as part of an agreement in which he neither admitted nor denied the allegations. Eddie Murray, the Hall of Famer who also played for the Orioles, also settled, for $358,151. SEC officials said he was tipped off by DeCinces.

A little more than a year later, he and the others were criminally indicted.